This is the first report to also document that miR-182-5p expression is significantly increased in bladder cancer tissues where it functions as an oncogene by inhibiting RECK and Smad4 expression and may be potentially useful as a prognostic biomarker. The gene discussed is RECK; the disease is urinary bladder carcinoma.